Last edition
News about Global Pharma
Cenra Healthcare has announced the expansion of its long-standing partnership with Dr. Reddy’s Laboratories (Taiwan) Ltd. to further improve access to affordable and clinically valuable treatments for patients in Taiwan.
Global Pharma | 22/07/2025 | By Dineshwori | 255
Sanofi to Acquire Vicebio for USD 1.6 Billion
Sanofi has entered into a definitive agreement to acquire Vicebio Ltd., a biopharma company developing next-generation respiratory vaccines, in a deal worth up to USD 1.6 billion, including an upfront payment of USD 1.15 billion.
Global Pharma | 22/07/2025 | By Mrinmoy Dey | 369
AstraZeneca Commits USD 50 Billion to Expand USA Manufacturing and R&D Amid Tariff Pressures
The new Virginia plant will manufacture active pharmaceutical ingredients for AstraZeneca’s upcoming weight-loss and cholesterol drugs, including an oral GLP-1 candidate and a PCSK9 inhibitor. The company said the investment could create tens of thousands of jobs, although exact figures were not disclosed.
Global Pharma | 22/07/2025 | By Darshana | 150
Akums Expands Analgesic Portfolio with New High-Concentration Paracetamol Oral Suspension
Akums Drugs and Pharmaceuticals has introduced Paracetamol Oral Suspension 500mg/5ml in the Indian market, strengthening its position in pain and fever management and adding a significant product to the analgesic and antipyretic category.
Global Pharma | 22/07/2025 | By Dineshwori | 432
Novo Nordisk Partners with Fangzhou to Transform Diabetes and Obesity Management
Novo Nordisk and Fangzhou have signed a Memorandum of Understanding (MoU) to collaborate on the management of serious chronic conditions, including diabetes and obesity. <br />
Global Pharma | 22/07/2025 | By Dineshwori | 417
FDA Appoints Dr. George F Tidmarsh as Director of Center for Drug Evaluation and Research
The US Food and Drug Administration (FDA) has appointed Stanford faculty member Dr. George Francis Tidmarsh as the new Director of the Center for Drug Evaluation and Research (CDER).
Global Pharma | 21/07/2025 | By Dineshwori | 540
CorestemChemon Partners with ATG Lifetech to Expand Global CRO Footprint
CorestemChemon, a South Korea–based GLP-certified preclinical CRO, has partnered with ATG Lifetech to co-develop advanced transcriptome and organoid-based platforms, aiming to deliver precision-driven, next-gen preclinical solutions to global pharma and biotech clients.
Global Pharma | 21/07/2025 | By Mrinmoy Dey | 152
Alembic Pharma Appoints Dr. Sachin Ghosalkar as Senior VP - SCM and Operations
Alembic Pharmaceuticals Ltd. has announced the appointment of Dr. Sachin Ghosalkar as Senior Vice President – Supply Chain Management (SCM) and Operations, designated as Senior Management Personnel of the company.
Global Pharma | 21/07/2025 | By Dineshwori | 394
Moderna Halts Plans for mRNA Manufacturing Facility in Japan Amid Business Uncertainty
The US-based vaccine maker announced on Friday that it would not proceed with its project at the Shonan Health Innovation Park (iPark) in Fujisawa, Kanagawa Prefecture. The decision follows “careful consideration given the current business environment,” according to a statement from Moderna’s Japan unit.
Global Pharma | 21/07/2025 | By Darshana | 393
FDA Drug Approvals Fall in 2024, But Small Pharma Fuels Innovation Surge
The US Food and Drug Administration (FDA) approved 127 innovator and biosimilar drugs in 2024, marking a decline from the 149 approvals recorded in 2023, according to a report by leading data and analytics firm GlobalData.
Global Pharma | 19/07/2025 | By Dineshwori | 503
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy